Back
BioXcel Therapeutics Stock Price Chart
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Sell
17
BTAI
BioXcel Therapeutics
Last Price:
0.60
Seasonality Move:
6.27%
7 Day Trial
ALL ACCESS PASS
$
7
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight buying pressure.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.59 | Buy |
| 20-day SMA: | 0.59 | Buy |
| 50-day SMA: | 0.76 | Sell |
| 200-day SMA: | 2.04 | Sell |
| 8-day EMA: | 0.58 | Buy |
| 20-day EMA: | 0.61 | Sell |
| 50-day EMA: | 0.79 | Sell |
| 200-day EMA: | 2.64 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 45.58 | Sell |
| Chaikin Money Flow: | 510394 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.65) | Buy |
| Bollinger Bands (100): | (0.65 - 1.67) | Sell |
BioXcel Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.60 while BTAI 8-day simple moving average is 0.59, which is a Buy signal.
- The stock price of BTAI is 0.60 while BioXcel Therapeutics 20-day SMA is 0.59, which makes it a Buy.
- BioXcel Therapeutics 50-day simple moving average is 0.76 while BTAI share price is 0.60, making it a Sell technically.
- BTAI stock price is 0.60 and BioXcel Therapeutics 200-day simple moving average is 2.04, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
17
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a Sell
The current BioXcel Therapeutics [BTAI] share price is $0.60. The Score for BTAI is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
24.56M
Price in USD:
0.60
Share Volume:
774.13K
BioXcel Therapeutics 52-Week Range
52-Week High:
5.62
52-Week Low:
0.51
Sell
17
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?
The BioXcel Therapeutics stock price is 0.60 USD today. -
Will BTAI stock go up or go down?
BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is BioXcel Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.60 while BTAI 8-day exponential moving average is 0.58, which is a Buy signal.
- The stock price of BTAI is 0.60 while BioXcel Therapeutics 20-day EMA is 0.61, which makes it a Sell.
- BioXcel Therapeutics 50-day exponential moving average is 0.79 while BTAI share price is 0.60, making it a Sell technically.
- BTAI stock price is 0.60 and BioXcel Therapeutics 200-day simple moving average is 2.64, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.12 per share, an increase this year of $4.08 per share, and an increase next year of $0.47 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
- BTAI Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting BioXcel Therapeutics is a Sell
- BioXcel Therapeutics Relative Strength Index (RSI) is 45.58, which suggest BioXcel Therapeutics is oversold
- The Bollinger Bands (25) for BioXcel Therapeutics is (0.55 - 0.65), which suggest BioXcel Therapeutics is a Sell
- The Bollinger Bands (100) for BioXcel Therapeutics is (0.65 - 1.67), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.